Medicare Enrolled

Dr. Waylon Steele, MSN, FNP-C

Nurse Practitioner - Family · Reading, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
2901 SAINT LAWRENCE AVE, Reading, PA 19606
6103010306
In practice since 2017 (9 years)
NPI: 1730627944 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Steele from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Steele? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Steele

Dr. Waylon Steele is a nurse practitioner - family in Reading, PA, with 9 years of NPI registration. Based on federal Medicare data, Dr. Steele performed 4,048 Medicare services across 2,220 unique beneficiaries.

Between the years covered by Open Payments, Dr. Steele received a total of $8,728 from 28 pharmaceutical and/or device companies across 366 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - family. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Steele is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 9 years in practice ▲ Top 1% volume in PA $8,728 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,048
Medicare services
Top 1% in PA for nurse practitioner - family
2,220
Unique beneficiaries
$38
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~450 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
1,371 $4 $10
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
615 $70 $186
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
511 $49 $131
Destruction of skin growths (warts/lesions), 1-14
This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface.
467 $62 $164
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
370 $25 $97
Skin biopsy, tangential
A procedure to remove a sample of the first identified skin growth for laboratory examination.
181 $49 $147
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
83 $58 $163
Destruction of 15 or more precancerous skin growths
This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer.
67 $101 $245
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
67 $90 $243
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
51 $8 $20
Shaving of skin growth, 0.6-1.0 cm
A minor procedure to shave off a skin growth on the body, arms, or legs that measures between 0.6 and 1.0 centimeters.
45 $61 $177
Destruction of skin growth, 15 or more growths 41 $75 $192
Additional skin growth biopsy
Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session.
36 $32 $73
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
32 $1 $2
Shaving of skin growth, 1.1-2.0 cm
This procedure involves shaving off a skin growth measuring between 1.1 and 2.0 centimeters from the body, arms, or legs.
27 $71 $198
Shaving of skin growth on face, 0.6-1.0 cm
This procedure involves shaving off a skin growth located on the face, ears, eyelids, nose, lips, or mouth. The size of the growth being removed is between 0.6 and 1.0 centimeters.
25 $74 $199
Simple drainage of skin abscess
A minor procedure to drain a localized collection of pus from the skin. The abscess is opened to allow the fluid to escape and promote healing.
24 $67 $182
Shaving of skin growth, 0.6-1.0 cm
A minor procedure to shave off a skin growth measuring 0.6 to 1.0 cm from the scalp, neck, hands, feet, or genitals.
18 $62 $178
Injection into skin growths, 1-7
A procedure involving the injection of medication into one to seven skin growths.
17 $29 $83
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,728
Total received (2021-2024)
Avg $2,182/year across 4 years
Top 2% in PA for nurse practitioner - family
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
28
Companies
366
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,302 (60.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,326 (38.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$100 (1.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,195
2023
$2,727
2022
$1,233
2021
$1,572

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$1,703
Galderma Laboratories, L.P.
$421
Arcutis Biotherapeutics, Inc.
$336
ABBVIE INC.
$209
UCB, Inc.
$190
Novartis Pharmaceuticals Corporation
$144
E.R. Squibb & Sons, L.L.C.
$74
Organogenesis Inc.
$23
Genentech USA, Inc.
$23
Incyte Corporation
$22
PFIZER INC.
$18
Boehringer Ingelheim Pharmaceuticals, Inc.
$16
Journey Medical Corporation
$15
Top 3 companies account for 77.0% of 2024 payments
All-time payments by company (2021-2024) ›
Janssen Biotech, Inc.
$3,692
Galderma Laboratories, L.P.
$1,738
ABBVIE INC.
$682
Arcutis Biotherapeutics, Inc.
$541
Novartis Pharmaceuticals Corporation
$280
UCB, Inc.
$221
VYNE Pharmaceuticals Inc.
$207
AbbVie Inc.
$187
GENZYME CORPORATION
$133
Solta Medical, a division of Bausch Health US, LLC
$130
Regeneron Healthcare Solutions, Inc.
$128
SUN PHARMACEUTICAL INDUSTRIES INC.
$102
E.R. Squibb & Sons, L.L.C.
$74
Incyte Corporation
$73
Genentech USA, Inc.
$58
PFIZER INC.
$57
Dermavant Sciences, Inc.
$52
Lilly USA, LLC
$51
EPI Health, LLC
$46
LEO Pharma Inc.
$44
Sun Pharmaceutical Industries Inc.
$40
Journey Medical Corporation
$38
Verrica Pharmaceuticals Inc.
$33
Amgen Inc.
$29
NOVARTIS PHARMACEUTICALS CORPORATION
$28
Organogenesis Inc.
$23
Almirall LLC
$22
Boehringer Ingelheim Pharmaceuticals, Inc.
$16
Top 3 companies account for 70.0% of all-time payments
Associated products mentioned in payments ›
ADBRY · AKLIEF · AMZEEQ · Absorica LD · BLU-U · Bimzelx · CLODERM · COSENTYX · DUPIXENT · DYSPORT · ENSTILAR · EPSOLAY · EUCRISA · Erivedge · HUMIRA · Ilumya · OPZELURA · ORACEA · Otezla · QBREXZA · REMICADE · RINVOQ · SKYRIZI · SPEVIGO · Seysara · Sotyktu · TALTZ · TREMFYA · TWYNEO · VTAMA · Winlevi · YCANTH · ZILXI · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (61%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for nurse practitioner - family in PA.

Looking for a nurse practitioner - family in Reading?
Compare family nurse practitioners in the Reading area by procedure volume, costs, and industry payment transparency.
Browse family nurse practitioners nearby

Geographic Context

Family nurse practitioners within 10 mi
350
Per 100K population
81.4
County median income
$77,684
Nearest hospital
HAVEN BEHAVIORAL HOSPITAL OF EASTERN PENNSYLVANIA
4.5 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Steele is a clinical cardiology specialist, with above-average Medicare volume (top 1% in PA), with low-engagement industry engagement in the top 2% of PA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Steele experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Steele performed 1,371 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Steele receive payments from pharmaceutical companies?
Yes. Dr. Steele received a total of $8,728 from 28 companies across 366 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Steele's costs compare to other family nurse practitioners in Reading?
Dr. Steele's average Medicare payment per service is $38. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Steele) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →